The uptake of the pharmacy-dispensed naloxone kit program in Ontario
This study aims to describe the initial uptake of naloxone through the ONPP and characteristics of the individuals receiving and pharmacies dispensing naloxone kits.
This study examines the association between suicide and exposure to angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
Ontario Prescription Opioid Tool: Update July 2019
This tool allows public access to data related to indicators for opioid prescribing in the province. It has been updated to include data up to March 2019 (April 2019 for naloxone) and two new indicators to capture individuals newly dispensed a prescription opioid for pain or opioid agonist therapy.
This study evaluates the risk of cardiac arrhythmias and other cardiovascular adverse events in older adults receiving mirabegron prescribed to treat overactive bladder.